Jeff Johnson is currently the New Technology Lead and Director, Global Engineering Services at Merck, where he is responsible for the assessment of new manufacturing technology for Merck's vaccine, biologics, and sterile manufacturing processes. He is also the co-leader of Merck's Single Use Technology initiative. Prior roles include Director of BioProcess Engineering, responsible for business case and concept development for new vaccine and biologics capital projects, and Director of Network Management for Therapeutic Protein Commercialization. Prior to Merck, he worked for Genzyme Corporation, Raytheon Engineers, and ARCO Chemical Co. He holds a BS in Chemical Engineering from the University of Rochester, a MS in Chemical Engineering from the University of Pennsylvania, and a Certificate in Biotechnology from Tufts University.